178

Immunology & Rheumatology
Focuses on rheumatic and immune diseases.
Sub Categories on Immunology & Rheumatology
Latest Articles
COVID-19 virus triggers antibodies from previous coronavirus infections: study

COVID-19 virus triggers antibodies from previous coronavirus infections: study

by The Translational Genomics Research InstituteCredit: CC0 Public DomainThe results of a study led by Northern Arizona University and the Translational Genomics Research Institute (TGen), an aff

COVID-19 virus triggers antibodies from previous coronavirus infections: study

by The Translational Genomics Research InstituteCredit: CC0 Public DomainThe results of a study led by Northern Arizona University and the Translational Genomics Research Institute (TGen), an aff
β-damascone: Using the aroma component of rose fragrance as a novel immunomodulator

β-damascone: Using the aroma component of rose fragrance as a novel immunomodulator

by Tokyo University of ScienceOveractivation of dendritic cells (DCs), components of the immune system, can cause immune diseases. β-damascone, a constituent of rose fragrance was identified as a

β-damascone: Using the aroma component of rose fragrance as a novel immunomodulator

by Tokyo University of ScienceOveractivation of dendritic cells (DCs), components of the immune system, can cause immune diseases. β-damascone, a constituent of rose fragrance was identified as a
New analysis finds belimumab improves cutaneous lupus erythematosus in patients with or without SLE

New analysis finds belimumab improves cutaneous lupus erythematosus in patients with or without SLE

by American College of RheumatologyForest plot of clinical response in CLE with or without SLE in belimumab users vs. non-users at week 52. Credit: Significant Improvement in Cutaneous Lupus Eryt

New analysis finds belimumab improves cutaneous lupus erythematosus in patients with or without SLE

by American College of RheumatologyForest plot of clinical response in CLE with or without SLE in belimumab users vs. non-users at week 52. Credit: Significant Improvement in Cutaneous Lupus Eryt
Research identifies protein that protects healthy joints from osteoarthritis

Research identifies protein that protects healthy joints from osteoarthritis

by University of DelawareThe blue area is the cell nucleus, the white area is F-actin, the structural scaffolding of the cells. Researchers discovered adseverin regulates the amount of F-actin in

Research identifies protein that protects healthy joints from osteoarthritis

by University of DelawareThe blue area is the cell nucleus, the white area is F-actin, the structural scaffolding of the cells. Researchers discovered adseverin regulates the amount of F-actin in
A 'backpack' full of multiple sclerosis therapy

A 'backpack' full of multiple sclerosis therapy

by Benjamin Boettner,Harvard UniversityShown on the left, is an immunofluorescence image of a monocyte with its outer cell membrane stained in green and nucleus stained in blue, and to which the

A 'backpack' full of multiple sclerosis therapy

by Benjamin Boettner,Harvard UniversityShown on the left, is an immunofluorescence image of a monocyte with its outer cell membrane stained in green and nucleus stained in blue, and to which the
Paradigm shift: How a risk-based program is changing health care use and outcomes for children with high-risk asthma

Paradigm shift: How a risk-based program is changing health care use and outcomes for children with high-risk asthma

by Le Bonheur Children's HospitalCredit: Pixabay/CC0 Public DomainLe Bonheur Children's Hospital's risk-based innovation program Changing High-Risk Asthma in Memphis through Partnership (C

Paradigm shift: How a risk-based program is changing health care use and outcomes for children with high-risk asthma

by Le Bonheur Children's HospitalCredit: Pixabay/CC0 Public DomainLe Bonheur Children's Hospital's risk-based innovation program Changing High-Risk Asthma in Memphis through Partnership (C
TAp63: A new protein drug target for rheumatoid arthritis

TAp63: A new protein drug target for rheumatoid arthritis

by Chiba UniversityGraphical abstract. Credit:JCI Insight(2023). DOI: 10.1172/jci.insight.164778Rheumatoid arthritis (RA) is an autoimmune disease characterized by joint deterioration. The

TAp63: A new protein drug target for rheumatoid arthritis

by Chiba UniversityGraphical abstract. Credit:JCI Insight(2023). DOI: 10.1172/jci.insight.164778Rheumatoid arthritis (RA) is an autoimmune disease characterized by joint deterioration. The
Platelet-rich plasma treatment shows efficacy for osteoarthritis

Platelet-rich plasma treatment shows efficacy for osteoarthritis

by Homa Shalchi,Baylor College of MedicineCredit: Pixabay/CC0 Public DomainA pilot study conducted by researchers at Baylor College of Medicine combined wearable technology and patient-reported

Platelet-rich plasma treatment shows efficacy for osteoarthritis

by Homa Shalchi,Baylor College of MedicineCredit: Pixabay/CC0 Public DomainA pilot study conducted by researchers at Baylor College of Medicine combined wearable technology and patient-reported
Smokers with rheumatoid arthritis face extra barriers to quitting

Smokers with rheumatoid arthritis face extra barriers to quitting

by University of OtagoSmokers who suffer from Rheumatoid Arthritis (RA) may need more targeted support to successfully quit a habit that will likely worsen their disease, latest University of Ota

Smokers with rheumatoid arthritis face extra barriers to quitting

by University of OtagoSmokers who suffer from Rheumatoid Arthritis (RA) may need more targeted support to successfully quit a habit that will likely worsen their disease, latest University of Ota
CAR T therapy shows long-lasting remissions in non-hodgkin lymphoma

CAR T therapy shows long-lasting remissions in non-hodgkin lymphoma

by Perelman School of Medicine at the University of PennsylvaniaCredit: Unsplash/CC0 Public DomainA significant number of non-Hodgkin lymphoma (NHL) patients in a Penn Medicine-initiated clinical

CAR T therapy shows long-lasting remissions in non-hodgkin lymphoma

by Perelman School of Medicine at the University of PennsylvaniaCredit: Unsplash/CC0 Public DomainA significant number of non-Hodgkin lymphoma (NHL) patients in a Penn Medicine-initiated clinical
Study links lower hydroxychloroquine dose to more hospitalizations for systemic lupus erythematosus flares

Study links lower hydroxychloroquine dose to more hospitalizations for systemic lupus erythematosus flares

by American College of RheumatologyCase-Crossover Study Design: In this case-crossover study, case periods were the 6-months prior to a hospitalization for SLE flare. Control periods were 6-month

Study links lower hydroxychloroquine dose to more hospitalizations for systemic lupus erythematosus flares

by American College of RheumatologyCase-Crossover Study Design: In this case-crossover study, case periods were the 6-months prior to a hospitalization for SLE flare. Control periods were 6-month
Clinical trial denounces use of platelet-rich plasma injections for knee joint osteoarthritis

Clinical trial denounces use of platelet-rich plasma injections for knee joint osteoarthritis

by University of MelbournePlatelet-rich plasma injections have become a popular form of treatment for painful joints in recent years but researchers have established they are no better than place

Clinical trial denounces use of platelet-rich plasma injections for knee joint osteoarthritis

by University of MelbournePlatelet-rich plasma injections have become a popular form of treatment for painful joints in recent years but researchers have established they are no better than place